11936
T. Aoyama et al. / Tetrahedron 63 (2007) 11933–11937
1
1H NMR (400 MHz, CDCl3): d 2.27 (3H, s), 4.48 (2H, s),
6.28 (1H, s), 7.21–7.40 (10H, m).
719, 696 cmꢁ1. H NMR (400 MHz, CDCl3): d 0.88 (3H,
t, J¼6.8 Hz), 1.26–1.30 (10H, m), 1.50 (2H, quint,
J¼7.3 Hz), 2.08 (3H, s), 2.53 (2H, t, J¼7.3 Hz), 4.41 (2H,
s), 5.87 (1H, s), 7.26–7.37 (5H, m).
3.2.3. 2-Benzylamino-4-methyl-5-phenethylthiazole (4c).
Mp 99–100 ꢀC (hexane/ethyl acetate). HRMS (TOF-CI)
calcd for C19H21N2S (MH+): 309.1425. Found: 309.1434.
IR (neat): 3200, 3065, 3025, 2896, 1593, 1494, 1452,
3.2.10. 2-Benzylamino-5-decyl-4-methylthiazole (4i). Mp
70 ꢀC (hexane/ethyl acetate). Anal. Calcd for C21H32N2S:
C, 73.20; H, 9.36; N, 8.13. Found: C, 72.99; H, 9.58; N,
8.10. HRMS (TOF-CI) calcd for C21H33N2S (MH+):
345.2364. Found: 345.2368. IR (neat): 3205, 3104, 3068,
1
1299, 744, 697 cmꢁ1. H NMR (400 MHz, CDCl3): d 1.97
(3H, s), 2.78–2.88 (4H, m), 4.41 (2H, s), 5.48 (1H, s),
7.13–7.36 (10H, m).
2917, 1594, 1466, 1454, 1300, 720, 695 cmꢁ1. H NMR
1
3.2.4. 2-Benzylamino-4-methyl-5-(4-methylbenzyl)thi-
azole (4d). Mp 157–158 ꢀC (hexane/ethyl acetate). Anal.
Calcd for C19H20N2S: C, 73.99; H, 6.54; N, 9.08. Found:
C, 73.90; H, 6.67; N, 8.99. HRMS (TOF-CI) calcd for
C19H21N2S (MH+): 309.1425. Found: 309.1426. IR (neat):
3151, 3062, 3029, 2917, 1571, 1512, 1451, 1293, 718,
(400 MHz, CDCl3): d 0.88 (3H, t, J¼6.8 Hz), 1.26–1.30
(14H, m), 1.51 (2H, quint, J¼7.3 Hz), 2.11 (3H, s), 2.54
(2H, t, J¼7.3 Hz), 4.42 (2H, s), 5.54 (1H, s), 7.27–7.38
(5H, m).
3.2.11. 5-Benzyl-2-butylamino-4-methylthiazole (4k). Mp
108–109 ꢀC (hexane/ethyl acetate). Anal. Calcd for
C11H12N2S: C, 64.67; H, 5.92; N, 13.71. Found: C, 64.43;
H, 5.70; N, 13.48. HRMS (TOF-CI) calcd for C11H13N2S
(MH+): 205.0799. Found: 205.0792. IR (neat): 3413, 3270,
1
696 cmꢁ1. H NMR (400 MHz, CDCl3): d 2.18 (3H, s),
2.31 (3H, s), 3.86 (2H, s), 4.38 (2H, s), 5.50 (1H, s), 7.05–
7.11 (4H, m), 7.26–7.36 (5H, m).
3.2.5. 2-Benzylamino-5-(4-chlorobenzyl)-4-methylthi-
azole (4e). Mp 151–152 ꢀC (hexane/ethyl acetate). HRMS
(TOF-CI) calcd for C18H18ClN2S (MH+): 329.0879. Found:
329.0884. IR (neat): 3150, 3061, 3023, 2915, 1572, 1489,
3062, 1629, 1523, 1494, 1330, 698 cmꢁ1 1H NMR
.
(400 MHz, CDCl3): d 2.19 (3H, s), 3.90 (2H, s), 4.88 (2H,
s), 7.17–7.31 (5H, m).
1
1466, 1295, 729, 697 cmꢁ1. H NMR (400 MHz, CDCl3):
3.2.12. 5-Benzyl-2-isobutylamino-4-methylthiazole (4l).
Mp 108 ꢀC (hexane/ethyl acetate). Anal. Calcd for
C15H20N2S: C, 69.19; H, 7.74; N, 10.76. Found: C, 69.31;
H, 7.71; N, 10.68. HRMS (TOF-CI) calcd for C15H21N2S
(MH+): 261.1425. Found: 261.1426. IR (neat): 3205, 3106,
d 2.16 (3H, s), 3.86 (2H, s), 4.39 (2H, s), 5.59 (1H, s), 7.10
(2H, d, J¼8.3 Hz), 7.25 (2H, d, J¼8.0 Hz), 7.27–7.34
(5H, m).
1
3.2.6. 2-Benzylamino-5-(4-ethoxy-4-oxobutyl)-4-methyl-
thiazole (4f). HRMS (TOF-CI) calcd for C17H23N2O2S
(MH+): 319.1480. Found: 319.1486. IR (neat): 3326, 3030,
2948, 1592, 1470, 1453, 1330, 759, 697 cmꢁ1. H NMR
(400 MHz, CDCl3): d 0.94 (6H, d, J¼6.8 Hz), 1.81–1.94
(1H, m), 2.19 (3H, s), 2.97 (2H, d, J¼6.8 Hz), 3.91 (2H,
s), 5.33 (1H, s), 7.18–7.32 (5H, m).
1
2979, 172, 1548, 1479, 1453, 1300, 701 cmꢁ1. H NMR
(400 MHz, CDCl3): d 1.24 (3H, t, J¼7.2 Hz), 1.83 (2H,
quint, J¼7.4 Hz), 2.05 (3H, s), 2.30 (2H, t, J¼7.4 Hz),
2.59(2H, t, J¼7.4 Hz), 4.11 (2H, q, J¼7.2 Hz), 4.40 (2H,
s), 6.32 (1H, s), 7.25–7.34 (5H, m).
3.2.13. 5-Benzyl-2-decylamino-4-methylthiazole (4m).
Mp 62–63 ꢀC (hexane/ethyl acetate). HRMS (TOF-CI) calcd
for C21H33N2S (MH+): 345.2364. Found: 345.2364. IR
(neat): 3153, 3088, 2921, 1565, 1470, 1454, 1297, 761,
3.2.7. 2-Benzylamino-5-(5-bromopentyl)-4-methylthi-
azole (4g). HRMS (TOF-CI) calcd for C16H22BrN2S
(MH+): 353.0687. Found: 353.0692. IR (neat): 3204, 2932,
699 cmꢁ1 1H NMR (400 MHz, CDCl3): d 0.88 (3H, t,
.
J¼7.0 Hz), 1.25–1.35 (14H, m), 1.58 (2H, quint,
J¼7.0 Hz), 2.19 (3H, s), 3.14 (2H, t, J¼7.0 Hz), 3.91 (2H,
s), 5.08 (1H, s), 7.18–7.31 (5H, m).
1
2153, 1699, 1590, 1454, 1358, 1275, 731, 701 cmꢁ1. H
NMR (400 MHz, CDCl3): d 1.43–1.57 (4H, m), 1.86 (2H,
quint, J¼6.9 Hz), 2.08 (3H, s), 2.56 (2H, t, J¼7.3 Hz),
3.39 (2H, t, J¼6.9 Hz), 4.41 (2H, s), 5.93 (1H, br s), 7.27–
7.37 (5H, m).
3.2.14. 5-Benzyl-2-cyclohexylamino-4-methylthiazole
(4n). HRMS (TOF-CI) calcd for C16H21N2S (MH+):
273.1425. Found: 273.1433. IR (neat): 3183, 3064, 2953,
1552, 1452, 1301, 762, 697 cmꢁ1 1H NMR (400 MHz,
.
3.2.8. 2-Benzylamino-4-methyl-5-(5-thiocyanatopen-
tyl)thiazole (4g0). Mp 87–88 ꢀC (hexane/ethyl acetate).
Anal. Calcd for C17H21N3S2: C, 61.59; H, 6.39; N, 12.68.
Found: C, 61.41; H, 6.18; N, 12.46. HRMS (TOF-CI) calcd
for C17H22N3S2 (MH+): 332.1255. Found: 332.1252. IR
(neat): 3198, 3096, 3028, 2917, 2149, 1594, 1466, 1455,
CDCl3): d 1.45–1.53 (2H, m), 1.54–1.63 (2H, m), 1.63–
1.72 (2H, m), 1.94–2.03 (2H, m), 2.19 (3H, s), 3.69–3.75
(1H, m), 3.92 (2H, s), 4.91 (1H, s), 7.19–7.32 (5H, m).
3.2.15. 5-Benzyl-2-phenethylamino-4-methylthiazole
(4o). Mp 139 ꢀC (hexane/ethyl acetate). Anal. Calcd for
C19H20N2S: C, 73.99; H, 6.54; N, 9.08. Found: C, 73.99;
H, 6.32; N, 9.17. HRMS (TOF-CI) calcd for C19H21N2S
(MH+): 309.1425. Found: 309.1424. IR (neat): 3096, 3082,
1304, 753, 698 cmꢁ1
.
1H NMR (400 MHz, CDCl3):
d 1.44–1.61 (4H, m), 1.83 (2H, quint, J¼7.3 Hz), 2.10
(3H, s), 2.58 (2H, t, J¼7.3 Hz), 2.92 (2H, t, J¼7.3 Hz),
4.42 (2H, s), 5.75 (1H, s), 7.27–7.37 (5H, m).
3060, 1590, 1492, 746, 695 cmꢁ1 1H NMR (400 MHz,
.
CDCl3): d 2.19 (3H, s), 2.90 (2H, t, J¼6.8 Hz), 3.44 (2H,
3.2.9. 2-Benzylamino-4-methyl-5-octylthiazole (4h). Mp
63–64 ꢀC (hexane/ethyl acetate). HRMS (TOF-CI) calcd
for C19H29N2S (MH+): 317.2051. Found: 317.2048. IR
(neat): 3204, 3103, 3028, 2915, 1593, 1465, 1454, 1301,
t, J¼6.8 Hz), 3.91 (2H, s), 5.01 (1H, s), 7.18–7.31 (10H, m).
3.2.16. 2-Allylamino-5-benzyl-4-methylthiazole (4p). Mp
111–112 ꢀC (hexane/ethyl acetate). Anal. Calcd for